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Disease 
ABSTRACT 
Alzheimer's Disease (AD) is said to be the most prevailing Neurogenerative Disease. The 
neurogenerative disease is stated in a gathering of disorders that affect the brain. Deep 
Learning, the avant-garde machine learning approach is well prominent and this approach has 
shown wonderful performance compared to traditional machine learning techniques to 
identify convoluted structures in complicated high dimensionality data especially within the 
realm of computer vision. The application of the Deep learning approach is to have an early 
observation and mechanized classification of Alzheimer's Disease. Nowadays, it has gained a 
great amount of recognition as neuro-imaging techniques have generated an extensive range 
of multimodal neuro-imaging data. Deep learning Techniques and neuro-imaging data for 
diagnostic classification of Alzheimer's Disease was carried out and has been scientifically 
reviewed by a publication. Scopus and Google Scholar hunt was used to find some useful 
papers on deep learning techniques for AD. These papers were judged, assessed, and 
classified with the algorithms and neuro-imaging techniques and then the discovery was 
summarized. The objective of this project is to discover the early symptoms of the disease 
which are varying from age to age while classifying different stages of it along the way and 
enhance the prediction and accuracy to our extent. 
 
1. INTRODUCTION 
Alzheimer’s disease is further manageable if the symptoms of Mild Cognitive Impairment 
(MCI) are in early stage. This disease is fundamentally associated with the fluctuations in 
brain which causes the deficiency of brain structure including the failing of neurons. In 
accordance with the Neurologists statements, there is no cure for this disorder. On the 
contrary unearthing early symptoms can help in early diagnosis of the disease. There are 
certain treatments which can put back the symptoms if they are looked after within the 
premature phases of the disease. Hence, an early identification of AD may be a major aspect 
for the patients affected by it. This disease is misperceived with standard ageing outcomes 
and hence Electroencephalography (EEG) has been present and defined as a constructive 
technique which will help to smoothen the progress of premature diagnosis while an efficient 
reason is it's simple to practice.  
EEG is employed to image brain activities and it registers the brain signal by means of 
electrodes affixed to the scalp. In addition to this, advanced neuroimaging techniques like 
resonance Imaging (MRI) and Positron Emission Tomography (TMI) have also been 
advanced and utilized within the diagnosis of AD. Deep learning methodologies like 
Convolutional Neural Network (CNN) or Recurrent Neural Network (RNN) which uses 
neuro-imaging data exclusive of extracting pre-processing for attribute selection have 
produced a greater accuracy for AD classification. Analysis of AD applying structural MRI 
and hybrid arrangement for creating a distinction among NC, MCI, and AD patients. EEG are 
regularly exercised for positive correlation of brain functionalities, which may stand utilized 
for monitoring brain motion, Non-linear analysis of EEG data displays the unique attributes 
to discover the diagnosis of neurological disorders, like Alzheimer, Epilepsy, and 
Parkinson’s. Numerous irregularities obtained in EEG signals of patients affected by AD 
embrace decelerating of EEG signals, moderated complexity of EEG signals and 
disconcertion in EEG synchrony. 
1.1 HISTORICAL BACKGROUND 
Alois Alzheimer, a German doctor, revealed the first instance of Alzheimer's disease in 1907. 
He initially observed Auguste Deter, a 51-year-elderly person, in 1901. Auguste's spouse Karl 
carried her to a psychological emergency clinic after she started displaying bizarre conduct, 
including hiding items, undermining neighbors, and blaming her husband of adultery. She 
additionally lost the capacity to do day by day exercises for example, cooking and 
housework. Auguste went under Alzheimer's consideration at a psychological clinic in 
Frankfurt. There he noticed and recorded her standards of conduct: she could talk yet not 
keep in touch with her own name, she could name items, for example, a pencil yet not the 
food she was eating, she was obliging occasionally however noisy and hostile at other times. 
He determined Auguste to have "presenile dementia".  
Upon her passing in 1906, Alzheimer's biopsy of her mind uncovered diffuse cortical decay 
and "specific changes in cortical cell bunches". Alzheimer depicted plaques and tangles of 
nerve filaments which scientists would distinguish in the 1980's as beta amyloid plaques and 
neurofibrillary tangles of tau. That year, Alzheimer gave a presentation on Auguste at a 
German psychiatry conference, asserting these cortical injuries to be the reason of her 
indications. He distributed a research paper the following year, and a psychiatry textbook in 
1910 named the problem 'Alzheimer's Disease.' The clinical symptomatic measures for AD 
were normalized in the U.S. in 1984. They were updated in 2011 and 2018 to make separate 
judgments for the preclinical, mild cognitive impairment (MCI) and dementia phases of AD 
furthermore, to perceive the role of biomarkers in AD analysis. 
1.2 PATHOGENESIS 
AD is a perplexing, multifactorial, neurodegenerative infection, coming about because of 
convoluted communications of one's hereditary makeup, education, age, and climate. 
Numerous speculations have established the framework to pick up agreement of the etiology 
of the infection, with one of the eldest being the cholinergic speculation. This theory depends 
on the way that AD patients show decrease in action of choline acetyltransferase and 
acetylcholinesterase in the cerebral cortex contrasted with the typical cerebrum. Postmortem 
brain tissue from patients with AD affirmed the decreased neurotransmitter pathway activity, 
uncovering that degeneration of cholinergic neurons and loss of cholinergic 
neurotransmission essentially contributes to the cognitive impairment found in those with 
AD. 
The Tau speculation has likewise been proposed, considering AD histopathology uncovers 
intraneuronal neurofibrillary sores comprised of tau proteins. Tau proteins are essentially 
found in neurons and are engaged with the assembly and stabilization of the neuronal 
microtubule organization. Tau protein becomes obsessive when the phosphorylation 
guideline gets unchecked and hyperphosphorylated tau proteins polymerize into fibers and 
become neurofibrillary tangles. This prompts breakdown of the underlying and administrative 
activities of the cytoskeleton and at that point prompts irregular morphology, axonal vehicle, 
also, synaptic capacity of neurons, consequently prompting neurodegeneration.  
 
Figure 1:  The amyloid (Aβ) cascade hypothesis 
 
These earlier speculations made ready to the broadly acknowledged hypothesis for the 
pathogenesis of AD: the amyloid cascade hypothesis. This hypothesis credits clinical 
sequelae of the sickness to the overproduction or diminished freedom of amyloid beta (Ab) 
peptides, which at that point prompts expanded statement of Ab, besides, prompting neuronal 
harm (Figure 1). The length of Ab shifts relying upon the posttranslational cleavage pattern 
of the transmembrane amyloid forerunner protein (APP). Ab is produced by cleavage of APP 
by means of one or the other b-or g-secretases, coming about in the scandalous insoluble Ab 
fibrils. Two principal types of Ab polymers assume an immediate part in the pathology of 
AD: Ab40 and Ab42. Ab40/Ab42 at that point oligomerizes, ventures to synaptic clefts, and 
meddles with synaptic flagging. These in the end further polymerize into insoluble amyloid 
fibrils that total into amyloid plaques. Inside the plaques, Ab peptides in b-sheet compliance 
polymerize into basically unmistakable structures, including fibrillar, protofibers and 
polymorphic oligomers. It is the deposition of these plaques diffusely all through the 
cerebrum that lead to microglial enactment, cytokine discharge, reactive astrocytosis, and an 
in general inflammatory reaction. These underlying changes lead to synaptic and neuronal 
loss and inevitable gross cerebral decay. Then again, should APP be handled by a-secretase in 
the solid grown-up, solvent b-amyloid is delivered, which has been connected to assume a 
part in neuronal versatility/endurance, is defensive against excitotoxicity, is significant for 
ahead of schedule CNS improvement, and has been demonstrated to be significant for 
advancing neural connection development. The hereditary qualities of AD ought to likewise 
be considered to assume a persuasive part in the pathogenesis, close by irritation, apoptosis, 
and plaque development. The APP quality situated on 21q21, referenced above, was the 
primary found causative quality of AD. Advances in hereditary research have recognized two 
unmistakable types of AD: Familial Alzheimer's Disease (FAD) and Sporadic Alzheimer 
Disease (SAD), with the last making up the dominant part of cases. Significant advances 
during the 1990s and mid 2000s uncovered that FAD is the consequence of autosomal 
predominant changes in APP, PSEN1 and PSEN2 qualities, situated on chromosome 21, 14, 
and 1, separately. Even more explicitly, PSEN1 and PSEN2 contain the vital amino corrosive 
deposits needed for the reactant dynamic site of gamma-secretase. Certain transformations of 
these qualities lead to expanded creation of Ab peptide and neurodegeneration. Undeniably 
more regularly, the genetic danger factor for SAD was recognized as the sort e4 allele on 
chromosome 19, of the gene for apolipoprotein E (APOE), a low-thickness lipoprotein 
transporter dwell. APOE is available in approximately 50- 60% of patients with AD 
contrasted with 20-25% in sound older grown-ups without the historical backdrop of familial 
AD. 
1.3 TESTING 
AD remains a clinical diagnosis and is reliant on a detailed history, cognitive assessment, and 
physical exam. Structural imaging is also an important component of the assessment for AD. 
Atrophy of the medial temporal lobes on magnetic resonance imaging (MRI) is considered a 
diagnostic marker for the mild cognitive impairment stage of AD. Similarly, hypometabolism 
in the parieto-temporal association area, posterior cingulate and precuneus on 
fluorodeoxyglucose PET imaging is associated with AD. 
2. PRELIMINARY DATA COLLECTION  
Publication databases are often accessed using the library portals of the schools or by 
individually registering on the websites. Several methods are available to retrieve data from 
the quality databases like Scopus, Clarivate, Science Direct, Mendeley, Research gate, 
Google Scholar etc. Scopus database accessed on 19th September has been considered during 
this paper because it is that the largest among the peer reviewed databases. List of the 
keywords used is given within the following section. 
 
2.1 Important keywords  
The important keywords required to carry the search were “Alzheimer’s”, “Machine 
Learning” and “MRI”. The other keywords are enumerated in table 1. 
Table 1 List of Keywords 
Keywords Number of Publications 
Alzheimer's Disease 126 
Machine Learning 106 
Magnetic Resonance Imaging 99 
Neurodegenerative Diseases 69 
Neuroimaging 57 
Brain 50 
Major Clinical Study 48 
Mild Cognitive Impairment 47 
Diagnostic Imaging 38 
Deep Learning 35 
Support Vector Machine 34 
Feature Extraction 33 
Cognitive Defect 27 
Computer Assisted Diagnosis 26 
Image Processing 26 
Convolutional Neural Network 22 
Disease Classification 22 
Learning Algorithms 20 
 
The search was further restricted to English publications only. There were 169 English 
publications. Table 2. shows the publications of different language. 
Table 2 Trends in publishing language 




Researchers have published 70.34% papers in journals, 18.60% papers in conference 
proceedings and 11.04% in book series as in table 3. 
Table 3 Publication type 
Publication Type Number of Publication Percentage from 169 
Journal 118 70.34% 
Conference Proceeding 32 18.60% 
Book Series 19 11.04% 
 
2.2 Highlights of preliminary data  
In this paper the preliminary investigation is completed supported the keywords that extracted 
169 publications from the Scopus database. Documents like journal papers, conference 
proceedings and book series were retrieved from 2018 to 2021 for the research area of 
Alzheimer’s disease classification. The publication count per annum is as shown in table 4. 
Analysis supported number of publications per annum is shown in figure 1. 
Table 4 Year wise publication count 








Figure 2 Yearly publishing trends (2018-21) 
 
2.3 Data investigation 
Through the conducted bibliometric review reveals about the typography of literatures 
available in the next section which will highlight the distinctness of the available literature 
and using the geographical dispersion and the contributions by different authors, where the 
papers were published and the affiliation statistics. 
3. BIBLIOMETRIC ANALYSIS 
To perform the bibliometric analysis two ways were used 
 Geographical region analysis 
 Statistics of affiliations, subject area, author statistics and document type. 
3.1 Geographical region analysis  
The geographical regions of attentiveness of the published papers are shown in figure 2 
which is drawn using GPS Visualizer tool from gpsvisualizer.com. Indian and Chinese 
publications are of the maximum number. Figure 3 shows the contribution in publications by 
different countries.  
Figure 3 Geographical locations of the study 
 
Figure 4: Analysis by country / Region 
 
3.2 Analysis based on subject area  
Categorization based on subject area is shown in figure 4. The analysis reveals that maximum 
number of research papers are published from the area of Computer science, Engineering 
followed by Medicine, Neuroscience and Mathematics. 
Figure 5 Analysis based on Subject area 
3.3 Analysis based on affiliation  
Contributions by different Universities worldwide in publishing research papers in the field 
of classification of Alzheimer’s disease is shown in figure 5. The research area of 
classification of Alzheimer’s disease dominated by the Indian and Chinese Universities listed 
in figure 5. Top ten Universities publishing in this field have been shown.  
 
Figure 6 Analysis based on Affiliation 
3.4 Analysis based on number of publications per author  
Key authors contributing to the field of classification of Alzheimer’s disease are depicted in 
figure 6. First ten authors were considered from the available accessed data from the Scopus 
database.  
 
Figure 7 Analysis based on publication per author 
3.5 Journal Statistics  
The publication source types are shown in figure 7. It is clear from figure 7 that 29.8% 
publications are conference proceedings, 65.5% publications are from journal, 1.2% from 
book series and 3.5% are review publications.  
Figure 8 Analysis based on document type 
3.6 Statistics by document source  
Figure 8 shows the statistics for publications in Classification of Alzheimer’s disease. From 
the available extracted data, it is apparent that maximum number of publications are from the 
Advances in Intelligent systems and computing journal.  
 
Figure 9 Analysis by document source 
4. LIMITATIONS OF THIS STUDY  
Different combinations of keywords were entered to explore the Scopus database for the 
aim of bibliometric review. A couple of important journals and articles which were not 
available in Scopus database could not be incorporated during this study. 
5. CONCLUSIONS  
Great advancement in computer intelligence and deep learning techniques, with the help 
of increase in computational power over the years, medical imaging sector has had a huge 
positive impact on classification and segmentation of neurodegenerative diseases. With 
new computer aided detection techniques for image analysis of MRI’s and EEG’s on the 
rise, early detection of neurodegenerative diseases such as Alzheimer’s Disease  has 
become more accurate and has helped doctors to get hold of the symptoms at an early 
stage . Although deep learning methods have a high impact on the quantitative chemical 
analysis of brain MRI, there's still difficulty find a strong, generic method. In this paper 
we reviewed various studies of brain structure and different classification techniques used 
for detection of Alzheimer’s disease for both MRI and EEG, which when used together 
along with a deep learning technique can significantly improve diagnostic accuracy. 
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